Advanced Therapies 2025
Now in its 5th year, Advanced Therapies Europe 2025 is an intentionally intimate event — limited to just 500 senior-level decision-makers — to ensure every conversation drives outcomes. Held in Barcelona, at the heart of Europe’s fast-growing biotech ecosystem, this is where strategic connections ignite progress and insights lead to action. Whether you're here to invest, scale, partner, or launch, ATE 2025 gives you the platform to make it happen.
The global cell and gene therapy market is projected to surpass $93 billion by 2030. Now is the time to align your strategy with where the field is heading
Cell and gene therapy is evolving rapidly — and so are the conversations shaping its future. Whether you’re supporting commercialisation, enabling tech transfer, working in regulation, logistics, or patient access, your role is critical to turning innovation into impact.
Advanced Therapies Europe 2025 (2–4 September, Barcelona) is the premier platform bringing together every part of the CGT ecosystem to foster meaningful collaboration and progress.
At this year's event, you'll:
- Gain insights from multi-stakeholder panels on regulatory alignment, commercialisation, and health system readiness
- Join cross-functional roundtables exploring the challenges of end-to-end therapy delivery
- Take part in 1:1 meetings curated to match you with collaborators, clients, and solution providers
You’ll also be networking with a curated community of 500+ professionals, including representatives from companies like Alpha Bronze, Banc de Sang i Teixits, ViroCell Biologics and Bayer — don’t get left behind while others move ahead.
Please note: attendance is based on pre-approval to ensure every connection counts. Apply today and secure your place before the early bird deadline on 30 May.
Biovia members benefit from 25% discount. Please contact us to obtain your discount code.